Helius Medical Technologies EPS Ratio 2011-2026 | HSDT

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Helius Medical Technologies

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-14.6	-52.1	-7.38	-11.8	-13	-1.26	-1.5	-0.1	-0.17	-0.03	-0.27	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.03	-52.1	-9.29

Quarterly EPS Ratio Helius Medical Technologies

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-32.9	-79.7	-0.51	-	-744	-485	-3.08	-	-5.49	-2.92	-4.42	-	-2.9	-0.97	-1.15	-	-2.01	-2.58	-1.65	-	-2.7	-2.9	-5.38	-	-0.22	-0.01	0.05	-	-0.19	-0.78	-0.06	-	-0.67	-0.31	-0.32	-	-0.04	0.04	-0.05	-0.04	0.03	-0.01	-	-0.04	-0.04	-0.1	-0.04	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.05	-744	-37.4

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
BioSig Technologies BSGM	-0.75	-	37.08 %	$ 85.7 M	USA
Axonics Modulation Technologies AXNX	-1.28	-	-	$ 3.31 B	USA
Dynatronics Corporation DYNT	-1.43	-	14.99 %	$ 929 K	USA
Aziyo Biologics AZYO	1.29	-	1.37 %	$ 20.5 M	USA
Align Technology ALGN	5.63	$ 164.69	-7.13 %	$ 12.3 B	USA
Acutus Medical AFIB	-2.81	-	-26.83 %	$ 2.62 M	USA
Sintx Technologies SINT	-6.16	$ 2.32	-4.13 %	$ 6.43 M	USA
Allied Healthcare Products AHPI	-0.48	-	3.58 %	$ 2.21 M	USA
Sensus Healthcare SRTS	-0.47	$ 3.8	-5.24 %	$ 62 M	USA
Stryker Corporation SYK	2.21	$ 328.87	-1.15 %	$ 126 B	USA
Alphatec Holdings ATEC	-0.96	$ 10.95	-4.99 %	$ 1.64 B	USA
Tactile Systems Technology TCMD	0.83	$ 26.55	-0.86 %	$ 607 M	USA
Conformis CFMS	-6.99	-	-	$ 16.4 M	USA
TELA Bio TELA	-0.83	$ 0.66	-11.27 %	$ 31 M	USA
Abbott Laboratories ABT	3.73	$ 105.12	0.53 %	$ 183 B	USA
Tandem Diabetes Care TNDM	-0.01	$ 21.37	-8.36 %	$ 1.45 B	USA
Cardiovascular Systems CSII	-0.94	-	0.15 %	$ 844 M	USA
Second Sight Medical Products EYES	-0.43	-	-0.97 %	$ 54.4 M	USA
Apollo Endosurgery APEN	-0.98	-	-	$ 475 M	USA
Boston Scientific Corporation BSX	1.96	$ 69.36	-1.15 %	$ 103 B	USA
Avinger AVGR	-23.3	-	-20.74 %	$ 369 K	USA
CONMED Corporation CNMD	1.52	$ 35.31	-3.63 %	$ 1.1 B	USA
NanoVibronix NAOV	-13.7	-	-	$ 1.08 M	USA
Viemed Healthcare VMD	0.38	$ 9.26	0.43 %	$ 360 M	USA
Cytosorbents Corporation CTSO	-0.38	$ 0.59	-1.05 %	$ 32.1 M	USA
Aethlon Medical AEMD	-8.58	$ 2.19	-3.52 %	$ 3.42 M	USA
Varex Imaging Corporation VREX	-1.7	$ 10.81	0.23 %	$ 448 M	USA
Edwards Lifesciences Corporation EW	1.84	$ 78.73	-4.1 %	$ 46 B	USA
Vivos Therapeutics VVOS	-2.22	$ 1.13	-5.04 %	$ 5.67 M	USA
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA
Beyond Air XAIR	-0.69	$ 0.69	-0.72 %	$ 46.7 M	USA
Xtant Medical Holdings XTNT	-0.12	$ 0.57	0.51 %	$ 76.2 M	USA
Zimmer Biomet Holdings ZBH	4.45	$ 88.4	-0.85 %	$ 18 B	USA
AdaptHealth Corp. AHCO	-0.52	$ 11.24	-1.49 %	$ 1.52 B	USA
Penumbra PEN	4.57	$ 335.31	-0.33 %	$ 13 B	USA
OrthoPediatrics Corp. KIDS	-1.69	$ 15.72	-3.85 %	$ 369 M	USA
Invacare Corporation IVC	-0.54	-	-	$ 24.7 M	USA
Ra Medical Systems RMED	-26	-	10.0 %	$ 610 K	USA
IRIDEX Corporation IRIX	-0.59	-	-	$ 16 M	USA